Clinicopathologic characteristics and long-term prognosis of scirrhous hepatocellular carcinoma

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1698-1707

  Lee, Jin Hee ^a   Choi, Moon Seok ^a   Gwak, Geum Yeon ^a   Lee, Joon Hyeok ^a   Koh, Kwang Cheol ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a   Choi, Dongil ^a   Park, Cheol Keun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hepatectomy; Prognosis; Recurrence; Scirrhous hepatocellular carcinoma; Survival

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD PUGH SCORE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SCIRRHOUS HEPATOCELLULAR CARCINOMA; SCORING SYSTEM; TREATMENT OUTCOME;

ADENOCARCINOMA, SCIRRHOUS; ADULT; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

EID: 84864277461     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2075-x     Document Type: Article

References (28)

1. Matsuura S, Aishima S, Taguchi K, et al. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology. 2005;47: 382-390. (Pubitemid 41428487)
2. Kurogi M, Nakashima O, Miyaaki H, Fujimoto M, Kojiro M. Clinicopathological study of scirrhous hepatocellular carcinoma. J Gastroenterol Hepatol. 2006;21:1470-1477. (Pubitemid 44154719)
3. Ishak KG, Goodman Z, Stocker JT. Hepatocellular carcinoma. In: Rosai J, Sobin LH, eds. Tumors of the Liver and Intrahepatic Bile Duct. 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 1999:199-230.
4. Iha H. Clinicopathological study on scirrhous hepatocellular carcinoma. A study of 12 resected cases. Acta Hepatol Jpn. 1994; 28:855-863.
5. Japan LCSGO. Survey and Follow-Up Study of Primary Liver Cancer in Japan. Report 15. Kyoto: Liver Cancer Study group of Japan; 2002.
6. Kim SH, Lee WJ, Lim HK, Park CK. Sclerosing hepatic carcinoma: helical CT features. Abdom Imaging. 2007;32:725-729. (Pubitemid 350060496)
7. Goshima S, Kanematsu M, Yamada T, et al. Small scirrhous hepatocellular carcinoma with central scar: MR imaging findings. J Magn Reson Imaging. 2002;16:741-745. (Pubitemid 35375573)
8. Yamashita Y, Fan ZM, Yamamoto H, et al. Sclerosing hepatocellular carcinoma: radiologic findings. Abdom Imaging. 1993;18: 347-351. (Pubitemid 23246587)
9. Yoshida J, Takayama T, Yamamoto H. Computed tomography of sclerosing hepatocellular carcinoma. Comput Med Imaging Graph. 1992;16:125-130.
10. Kim SR, Imoto S, Nakajima T, et al. Scirrhous hepatocellular carcinoma displaying atypical findings on imaging studies. World J Gastroenterol. 2009;15:2296-2299.
11. Kim SH, Lim HK, Lee WJ, Choi D, Park CK. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. Eur J Radiol. 2009;69:123-130.
12. Sugiki T, Yamamoto M, Taka K, Nakano M. Specific characteristics of scirrhous hepatocellular carcinoma. Hepatogastroenterology. 2009;56:1086-1089.
13. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430. (Pubitemid 32844200)
14. Bruis J, Sherman M. AASLD practice guideline: management of hepatocellular carcinoma. Hepatology. 2005;42:1209-1235.
15. International Union Against Cancer (UICC). In: Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 5th ed. New York. Wiley-Liss; 1997.
16. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? J Hepatol. 2004;41:344-350. (Pubitemid 39177643)
17. Okamura N, Yoshida M, Shibuya A, Sugiura H, Okayasu I, Ohbu M. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Pathol Int. 2005;55: 724-731. (Pubitemid 41726939)
18. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978-988. (Pubitemid 34810558)
19. Yeh CN, Hung CF, Lee KF, Chen MF. Sclerosing hepatocellular carcinoma: clinicopathologic features in seven patients from Taiwan and review of the literature. Hepatogastroenterology. 2005;52:1201-1205.
20. Kim BS, Lee SG, Hwang S, et al. Surgical treatment of sclerosing hepatocellular carcinoma. Korean J Hepatol. 2006;12:412-419.
21. Ikai I, Itai Y, Okita K, et al. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res. 2004;28:21-29. (Pubitemid 38145784)
22. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology. 2006;238:150-155. (Pubitemid 43010591)
23. Valls C, Guma A, Puig I, et al. Intrahepatic peripheral cholan-giocarcinoma: CT evaluation. Abdom Imaging. 2000;25:490-496.
24. Yoshikawa J, Matsui O, Kadoya M, Gabata T, Arai K, Takashima T. Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr. 1992;16: 206-211.
25. Jeon TY, Kim SH, Lee WJ, Lim HK. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging. 2010;35:337-345.
26. Yamashita Y, Fan ZM, Yamamoto H, et al. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging. 1994;4:83-90.
27. Troeger JS, Schwabe RF. Hypoxia and hypoxia-inducible factor 1alpha: potential links between angiogenesis and fibrogenesis in hepatic stellate cells. Liver Int. 2011;31:143-145.
28. Copple BL, Bai S, Burgoon LD, Moon JO. Hypoxia-inducible factor-1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int. 2011;31:230-244.